Cure21 Bioscience Private Limited - Company Profile

It is a chemicals private limited company based in Indore, Madhya Pradesh, India, established in 2021.
2021 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Cure21 Bioscience Private Limited

Cure21 Bioscience Private Limited, a active private limited company, was established on 16 January 2021 in Indore, Madhya Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230MP2021PTC054531. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹50.00 K .

Its leadership includes Apurva Gopaldas Vaishnav (Director), Chetan Singh Mandloi (Director). It is based at Rh-136, Silver Springs-1 Jal Enclave Bypass Road, Mundla Nayata, Indore, Madhya Pradesh, 452020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MP2021PTC054531

  • Registration Number

    054531

  • Incorporation Date

    16 January 2021

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹50.00 K

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 50.00 K
  • Company Age 5 Year, 24 Days
Company report

Cure21 Bioscience Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cure21 Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Cure21 Bioscience Private Limited?
Current Directors
Name Designation Appointment Date Status
Apurva Gopaldas Vaishnav Director 16 Jan 2021 Current
Chetan Singh Mandloi Director 16 Jan 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cure21 Bioscience.

Enhance accessibility to Cure21 Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cure21 Bioscience revenue growth over time
Cure21 Bioscience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cure21 Bioscience?

Unlock access to Cure21 Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cure21 Bioscience?

Cure21 Bioscience has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cure21 Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cure21 Bioscience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cure21 Bioscience
Recent Activity within the Organization
  • Director Appointment

    Progress on Apurva Gopaldas Vaishnav was appointed as a Director was appointed as a Director on 16 Jan 2021 & has been associated with this company since 5 years 24 days . was documented.

  • Director Appointment

    The activity Chetan Singh Mandloi was appointed as a Director was appointed as a Director on 16 Jan 2021 & has been associated with this company since 5 years 24 days . was completed.

  • Company Incorporation

    The activity Cure21 Bioscience Private Limited was registered on 16 Jan 2021 with Roc Gwalior & aged 5 years 24 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cure21 Bioscience Private Limited?

The CIN of Cure21 Bioscience Private Limited is U24230MP2021PTC054531.

Where is Cure21 Bioscience Private Limited headquartered?

Cure21 Bioscience Private Limited is headquartered at Rh-136, Silver Springs-1 Jal Enclave Bypass Road, Mundla Nayata, Indore, Madhya Pradesh, 452020.

When was Cure21 Bioscience Private Limited incorporated?

Cure21 Bioscience Private Limited was incorporated on 16 January 2021.

Who are the current directors of Cure21 Bioscience Private Limited?

The current directors of Cure21 Bioscience Private Limited are

What is the primary industry of Cure21 Bioscience Private Limited?

The primary industry of Cure21 Bioscience Private Limited is Chemicals.

Is Cure21 Bioscience Private Limited a listed company?

Cure21 Bioscience Private Limited is unlisted.

What is the capital structure of Cure21 Bioscience Private Limited?

The authorized capital of Cure21 Bioscience Private Limited is ₹0.50 M, and the paid-up capital is ₹50.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available